Trinity Biotech plc (ADR) (NASDAQ:TRIB)

CAPS Rating: 5 out of 5

The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.

Recs

0
Player Avatar Rocket042001 (64.20) Submitted: 4/2/2008 8:45:42 PM : Outperform Start Price: $4.46 TRIB Score: +149.46

Undervalued.

Featured Broker Partners


Advertisement